de Mol van Otterloo S R, Westerhoff J M, Leer T, Rutgers R H A, Meijers L T C, Daamen L A, Intven M P W, Verkooijen H M
Department of Radiation Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3508 GA Utrecht, the Netherlands.
Division of Imaging, University Medical Center Utrecht, Utrecht, the Netherlands.
Tech Innov Patient Support Radiat Oncol. 2023 Nov 25;29:100224. doi: 10.1016/j.tipsro.2023.100224. eCollection 2024 Mar.
Online adaptive MR-guided radiotherapy (MRgRT) is a relatively new form of radiotherapy treatment, delivered using a MR-Linac. It is unknown what patients expect from this treatment and whether these expectations are met. This study evaluates whether patients' pre-treatment expectations of MRgRT are met and reports patients' on-table experience on a 1.5 T MR-Linac.
All patients treated on the MR-Linac from November 2020 until April 2021, were eligible for inclusion. Patient expectation and experience were captured through questionnaires before, during, and three months after treatment. The on-table experience questionnaire included patient' physical and psychological coping. Patient-expected side effects, participation in daily and social activity, disease outcome and, disease related symptoms were compared to post-treatment experience.
We included 113 patients who were primarily male (n = 100, 89 %), with a median age of 69 years (range 52-90). For on-table experience, ninety percent of patients (strongly) agreed to feeling calm during their treatment. Six and eight percent of patients found the treatment position or bed uncomfortable respectively. Twenty-eight percent of patients felt tingling sensations during treatment. After treatment, 79 % of patients' expectations were met. Most patients experienced an (better than) expected level of side effects (75 %), participation in daily- (83 %) and social activity (86 %) and symptoms (78 %). However, 33 % expected more treatment efficacy than experienced.
Treatment on the 1.5 T MR-Linac is well tolerated and meets patient expectations. Despite the fact that some patients expected greater treatment efficacy and the frequent occurrence of tingling sensations during treatment, most patient experiences were comparable or better than previously expected.
在线自适应磁共振引导放射治疗(MRgRT)是一种相对较新的放射治疗形式,通过磁共振直线加速器进行。目前尚不清楚患者对这种治疗的期望是什么,以及这些期望是否得到满足。本研究评估患者对MRgRT治疗前的期望是否得到满足,并报告患者在1.5T磁共振直线加速器上的治疗体验。
2020年11月至2021年4月期间在磁共振直线加速器上接受治疗的所有患者均符合纳入标准。通过治疗前、治疗期间和治疗后三个月的问卷来了解患者的期望和体验。治疗体验问卷包括患者的身体和心理应对情况。将患者预期的副作用、参与日常和社交活动的情况、疾病结局以及与疾病相关的症状与治疗后的体验进行比较。
我们纳入了113例患者,其中男性居多(n = 100,89%),中位年龄为69岁(范围52 - 90岁)。对于治疗体验,90%的患者(强烈)同意在治疗期间感到平静。分别有6%和8%的患者认为治疗体位或治疗床不舒服。28%的患者在治疗期间感到刺痛。治疗后,79%的患者期望得到了满足。大多数患者经历的副作用水平(75%)、参与日常活动(83%)和社交活动(86%)以及症状(78%)均(优于)预期。然而,33%的患者期望的治疗效果比实际体验的更好。
在1.5T磁共振直线加速器上进行治疗耐受性良好,符合患者期望。尽管一些患者期望有更高的治疗效果,且治疗期间频繁出现刺痛感,但大多数患者的体验与之前预期相当或更好。